Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …

Presently, different types of eye diseases, such as glaucoma, myopia, infection, and dry eyes
are treated with topical eye drops. However, due to ocular surface barriers, eye drops …

Oral drug delivery of microparticles demonstrates shortcomings like aggregation, decreased
loading capacity and batch-to-batch variation, which limits its scale-up. Later, porous …

Diabetes mellitus is characterized by altered blood sugar homeostasis. Diabetic mortality
rates are escalating in developed countries by the day. Currently, no effective treatment and …

Glaucoma is one of the leading causes of blindness. Therapies available suffer from several
drawbacks including low bioavailability, repeated administration and poor patient …

Extensive research is currently being conducted into novel ocular drug delivery systems
(ODDS) that are capable of surpassing the limitations associated with conventional …

Posterior segment eye diseases present a challenge in treatment due to the complex
structures in the eye that serve as robust static and dynamic barriers, limiting the penetration …

This study was meant to describe a Poloxamer hydrogel combining Chitosan-N-acetyl-L-
cysteine (CNAC) nanoparticles to increase loading and sustained intravitreal administration …

Chronic ocular diseases can seriously impact the eyes and could potentially result in
blindness or serious vision loss. According to the most recent data from the WHO, there are …

The occurrence of diabetes mellitus (DM) is increasing rapidly at an accelerating rate
worldwide. The status of diabetes has changed over the last three generations; whereas …